GeneDx Executive and Leadership Team

Bryan Dechairo, the Chief Operating Officer at GeneDx, orchestrates the company's day-to-day operational activities and strategic execution. This executive's purview encompasses the efficient functioning of laboratory operations, supply chain management, and the seamless delivery of genomic testing services to healthcare providers and hospitals. Dechairo drives initiatives to enhance operational efficiency, improve turnaround times for genetic analyses, and ensure the highest standards of quality control across all testing platforms. The Chief Operating Officer plays a pivotal role in scaling GeneDx's capabilities to meet growing market demand, particularly in the specialized area of rare disease diagnostics. By optimizing workflows and resource allocation, Bryan Dechairo directly supports the company's ability to leverage its extensive genomic datasets for clinical testing and research. This leadership ensures that GeneDx maintains its competitive edge and continues to expand its impact in the genomic diagnostics sector.

Rhonda Brandon, the Chief Information Officer at GeneDx, directs the company's entire information technology infrastructure and strategy. This leadership role involves architecting and maintaining the secure, scalable systems essential for managing GeneDx's vast genomic datasets and clinical testing operations. Brandon oversees the development and implementation of advanced data management solutions, ensuring compliance with stringent healthcare regulations and data privacy standards. The Chief Information Officer's responsibilities extend to driving technological innovation, enhancing cybersecurity measures, and optimizing the digital tools that support laboratory operations and client interactions. By ensuring robust IT performance, Brandon directly enables the company's mission to provide accurate and timely genetic diagnostics, supporting healthcare providers and researchers across the United States and globally. This executive's focus on technological advancement is critical for GeneDx's continued growth and its position as a leader in genomic diagnostics.

Joseph DeMarte, the Senior Vice President, Corporate Operations and Chief of Staff at GeneDx, provides critical oversight for key corporate functions and acts as a strategic advisor. This dual role involves managing essential operational aspects of the business while also serving as a direct liaison to executive leadership, ensuring alignment across departments. DeMarte's responsibilities include driving strategic projects, optimizing internal processes, and facilitating effective communication between the executive team and other organizational units. The Senior Vice President, Corporate Operations and Chief of Staff also plays a significant part in implementing corporate policies and ensuring operational efficiency aligns with GeneDx's broader business objectives. By coordinating cross-functional initiatives and supporting strategic decision-making, Joseph DeMarte directly contributes to the company's ability to advance its mission in genomic diagnostics and support patient access to testing. This executive's comprehensive operational and strategic support is vital for GeneDx's continued development.

Linda Genen, the Chief Medical Officer at GeneDx, leads the company's clinical strategy and medical affairs, ensuring the scientific integrity and clinical utility of its genomic diagnostic offerings. This executive's focus is on translating complex genetic research into actionable diagnostic tests for rare and inherited disorders, serving healthcare providers and hospitals. Genen oversees the interpretation of genetic testing results, guides the development of new diagnostic methodologies, and ensures that GeneDx's services align with the latest medical advancements and patient needs. The Chief Medical Officer also plays a crucial role in communicating the clinical value of GeneDx's extensive rare disease genomic dataset to the medical community and research partners. By championing clinical excellence, Linda Genen directly supports GeneDx's mission to improve patient outcomes through precise genetic diagnosis and facilitates the company's contribution to drug discovery and health system research. This leadership ensures the highest standards of medical expertise guide GeneDx's operations.

Heidi Chen, the Chief Legal Officer & Corporate Secretary at GeneDx, provides comprehensive legal counsel and oversees corporate governance for the organization. This executive's responsibilities encompass managing all legal affairs, ensuring compliance with federal and state regulations pertinent to the healthcare and biotechnology sectors, and safeguarding the company's intellectual property. Chen directs the legal framework supporting GeneDx's commercial operations, including its Nasdaq listing and contractual agreements with healthcare providers and partners. The Chief Legal Officer & Corporate Secretary also plays a critical role in advising the Board of Directors and executive team on legal risks and strategic opportunities. By ensuring robust legal and ethical compliance, Heidi Chen directly supports GeneDx's mission to provide advanced genomic diagnostics while maintaining the highest standards of corporate integrity and operational transparency. This leadership is essential for navigating the complex regulatory landscape of the diagnostics industry.